Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Philanthropist gives $650m to Broad Institute for psychiatric research

24-Jul-2014 - Philanthropist Ted Stanley has gifted $650m to the Broad Institute as part of a wider attempt to galvanize research on psychiatric disorders and bring new treatments to market. 

News in brief

ABL buys French testing services lab for global reach

23-Jul-2014 - US CMO Advanced Bioscience Laboratories (ABL) has bought French immunogenicity services firm Platine Pharma citing additional global reach as the driver for the deal.

Harlan joins with French CRO to deliver more preclinical services

17-Jul-2014 - Preclinical CRO Harlan Laboratories has partnered with French CRO Fluofarma to strengthen the companies’ drug discovery and translational medicine services.

Charles River loses $12m National Cancer Institute contract

14-Jul-2014 - The US National Cancer Institute (NCI) recently terminated a contract with Charles River Laboratories (CRL) to supply rodents for cancer research.

Peakdale adds discovery offering to PE-backed testing services group

08-Jul-2014 - Pharma services firm Peakdale Molecular has joined with two UK environmental testing providers to form Concept Life Sciences in a private-equity backed agreement.

Petition calls on FDA to amend informed consent requirements

03-Jul-2014 - The Center for Responsible Science  has asked the US FDA to adopt informed consent rules which ensure that trial participants know the experimental drugs they receive may be unsafe or ineffective....

Lonza says stem cell reprogramming makes for better preclinical models

25-Jun-2014 - Lonza has launched a new stem cell reprogramming and maintenance system that has already been used to support US NIH and pharmaceutical company preclinical drug development projects.

Crown: improving animal irradiation can unlock failed drug candidates

24-Jun-2014 - The ability to pinpoint radiotherapy in animal testing could give failed cancer drug candidates a new lease of life, says preclinical CRO (contract research organisation) Crown Biosciences.

US NIH: preclinical research needs more female animals

18-Jun-2014 - The US National Institutes of Health (NIH) has unveiled a policy that will balance testing on male and female animals and cells in preclinical tests.

Covance CFO says early stage business is mostly back on track

12-Jun-2014 - Sounding upbeat on Covance’s recent gains in its early stage clinical business, CFO Alison Cornell expressed a conservative amount of optimism that growth will continue.

Celerion partnership aims to strengthen early phase research in South Korea

03-Jun-2014 - A few months after announcing its arrival in South Korea, Celerion and the Korean Drug Development Fund (KDDF) have agreed to collaborate to provide drug development expertise and support for...

Evotec looks to tap anti-infective research market with CRO Euprotec buy

29-May-2014 - Evotec has acquired all shares in UK-based specialist CRO Euprotec for as much as $5.26m to add anti-infective drug discovery services to its offerings.

$27m investment sees Crown team with China’s biggest mutant mouse org

19-May-2014 - Crown Biosciences has partnered with China’s biggest producer of mutant mice to build better experimental models for its cancer research sponsors, as part of its $26.5m (£16m) venture funding.


CROs commit to animal research openness

14-May-2014 - Contract research organisations Covance, Harlan, Sequani, Charles River Laboratories and Huntingdon Life Sciences have signed an agreement to be open about their animal research.


PRA adds large molecule bioanalytical capabilities to Kansas lab

13-May-2014 - CRO PRA announced Tuesday that it will add large molecule bioanalysis services in its Lenexa, Kansas, laboratory. 

Huntingdon buys Harlan to form 3rd largest preclinical CRO

07-May-2014 - Huntingdon Life Sciences has acquired contract research and animal models firm Harlan Laboratories, making it the third largest preclinical research organisation, according to the company.

Bayer teams with Cenix in RNAi tech discovery deal

05-May-2014 - Bayer has inked a deal with preclinical CRO Cenix BioScience to use its genome-scale RNA interference (RNAi) platform to target an undisclosed disease.

Crown and SNBL partner for challenging Japanese CRO market

29-Apr-2014 - Crown Bioscience has teamed up with Shin Nippon Biomedical Laboratories (SNBL) to navigate obstacles in the Japanese outsourcing market.

Biopharma turns to outsourcing for more common, simple tasks, survey finds

29-Apr-2014 - Biopharma is ramping up the outsourcing of some of the easier tests while tasks such as downstream process development and QbD services are being outsourced less, according to a new...

Harlan partners with Invenium to move further into Asia-Pacific region

28-Apr-2014 - Toxicology services provider Harlan Laboratories has selected Invenium Pharmacology as its exclusive agent for Harlan’s Contract Research Services (CRS) in Australia, Southeast Asia and New Zealand.

AMRI: discovery services demand still strong despite closing NY plant

17-Apr-2014 - AMRI says its long-term outlook remains positive with continued demand for its contract research services despite plans to shutter a Discovery and Development Services facility.

Debiopharm selects CRO Evotec for early cancer drug discovery deal

08-Apr-2014 - CRO Evotec AG will help Debiopharm identify and develop novel compounds with the potential to treat multiple forms of solid tumours and leukaemias with defined genetic alterations under a collabortation announced...

Completed Galapagos deal to boost 2014 sales by $70m for Charles River

02-Apr-2014 - Argenta and BioFocus will add approximately $70m (€51m) to Charles River Laboratories’ 2014 revenues, the firm and an analyst say.

Convergence selects Evotec to help develop pain treatment

01-Apr-2014 - Convergence Pharmaceuticals has entered into a research alliance with CRO Evotec to discover and develop compounds against a novel GPCR pain target.

Biotech and pipeline refills add to preclinical turnaround, say analysts

27-Mar-2014 - Demand from biotech firms and Big Pharma’s need to refill its pipeline is driving the preclinical services industry, say analysts at this year’s Society of Toxicology (SOT) meeting.

Key Industry Events


Access all events listing

Our events, Events from partners...